Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.67 |
| ▸ | ATM | Q13315 | 1/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CASP6 | P55212 | 2/20 | 0.41 |
| ▸ | ESPL1 | Q14674 | 1/20 | 0.41 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HSPB1 | P04792 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TTR | P02766 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29385912 | 0.80 | TDP1 (1.00) | TDP1ATMHIF1AALDH1A1VCAM1 | |
| SCHEMBL57112 | 0.80 | TDP1 (1.00) | TDP1ATMHIF1AALDH1A1VCAM1 | |
| SCHEMBL9225061 | 0.79 | TSHR (0.58) | TDP1ATMHIF1AALDH1A1TSHR | |
| SCHEMBL1637306 | 0.78 | ALDH1A1 (0.70) | TDP1ATMHIF1AALDH1A1VCAM1 | |
| SCHEMBL31121788 | 0.78 | TDP1 (0.96) | TDP1ATMHIF1AALDH1A1VCAM1 | |
| SCHEMBL31474855 | 0.78 | ALDH1A1 (0.70) | TDP1ATMHIF1AALDH1A1VCAM1 | |
| SCHEMBL6619 | 0.77 | TDP1 (0.64) | TDP1ATMHIF1AALDH1A1VCAM1 | |
| SCHEMBL247992 | 0.77 | TSHR (0.67) | TDP1ATMHIF1AALDH1A1VCAM1 | |
| SCHEMBL29348 | 0.77 | MAPK1 (0.64) | TDP1ATMHIF1AALDH1A1VCAM1 | |
| SCHEMBL375963 | 0.77 | TDP1 (0.64) | TDP1ATMHIF1AALDH1A1VCAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113260691-B | Luminescent solar concentrator comprising dithienyl pyridine thiadiazole compound | 艾尼股份公司 | 2024-02-09 | — | — | CN | disclosed |
| US-11713314-B2 | Disubstituted diaryloxybenzoheterodiazole compounds | ENI S.P.A. (IT) | 2023-08-01 | — | — | US | disclosed |
| US-11706979-B2 | Disubstituted diaryloxybenzoheterodiazole compounds | ENI S.P.A. (IT) | 2023-07-18 | — | — | US | disclosed |
| EP-3737678-B1 | PROCESS FOR THE PREPARATION OF DISUBSTITUTED DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS | ENI SPA (IT) | 2022-06-29 | — | — | EP | disclosed |
| US-20220165959-A1 | DISUBSTITUTED FLUOROARYLOXYBENZOHETERODIAZOLE COMPOUNDS | ENI S.P.A. (IT) | 2022-05-26 | — | — | US | disclosed |
| EP-3941995-A1 | DISUBSTITUTED FLUOROARYLOXYBENZOHETERODIAZOLE COMPOUNDS | ENI S.p.A. (IT) | 2022-01-26 | — | — | EP | disclosed |
| US-20210408393-A1 | Disubstituted Diaryloxybenzoheterodiazole Compounds | ENI S.P.A. (IT) | 2021-12-30 | — | — | US | disclosed |
| US-11208406-B2 | Disubstituted diaryloxybenzoheterodiazole compounds | ENI S.P.A. (IT) | 2021-12-28 | — | — | US | disclosed |
| CN-113840824-A | Disubstituted fluoroaryloxybenzoheterodiazole compounds | 艾尼股份公司 | 2021-12-24 | — | — | CN | disclosed |
| EP-3898889-A1 | LUMINESCENT SOLAR CONCENTRATOR COMPRISING DITHIENYLPYRIDINETHIADIAZOLE COMPOUNDS | ENI S.p.A. (IT) | 2021-10-27 | — | — | EP | disclosed |
| US-20150182549-A1 | METHOD FOR ENZYMATIC GLYCOSYLATION OF OLIGOSACCHARIDES FROM MAMMALIAN ANIMAL MILK | GLYCOM A/S (DK) | 2015-07-02 | — | — | US | disclosed |
| US-20150183816-A1 | MODIFIED GALACTOOLIGOSACCHARIDES | GLYCOM A/S (DK) | 2015-07-02 | — | — | US | disclosed |
| EP-2864492-A1 | MODIFIED GALACTOOLIGOSACCHARIDES | Glycom A/S (DK) | 2015-04-29 | — | — | EP | disclosed |
| EP-2864344-A1 | METHOD FOR ENZYMATIC GLYCOSYLATION OF OLIGOSACCHARIDES FROM MAMMALIAN ANIMAL MILK | Glycom A/S (DK) | 2015-04-29 | — | — | EP | disclosed |
| US-20140234912-A1 | METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | GLYCOM A/S (DK) | 2014-08-21 | — | — | US | disclosed |
| EP-2707493-A1 | METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | Glycom A/S (DK) | 2014-03-19 | — | — | EP | disclosed |
| WO-2013190529-A1 | GLYCOSYLATED GALACTOSYL DISACCHARDDES, METHODS FOR THEIR PRODUCTION AND THEIR USE IN CONSUMABLE PRODUCTS | GLYCOM A/S (DK) | 2013-12-27 | — | — | WO | disclosed |
| WO-2013190531-A1 | GLYCOSYLATED GALACTOSYL DISACCHARIDES, METHODS FOR THEIR PRODUCTION AND THEIR USE IN CONSUMABLE PRODUCTS | GLYCOM A/S (DK) | 2013-12-27 | — | — | WO | disclosed |
| WO-2013190530-A1 | MODIFIED GALACTOOLIGOSACCHARIDES | GLYCOM A/S (DK) | 2013-12-27 | — | — | WO | disclosed |
| WO-2012156897-A1 | METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | GLYCOM A/S (DK) | 2012-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210408393-A1 | Disubstituted Diaryloxybenzoheterodiazole Compounds | SCLY, NR2E3, CDK15 | TDP1 4805/4885ATM 4493/4885HIF1A 4421/4885 |
| US-11713314-B2 | Disubstituted diaryloxybenzoheterodiazole compounds | SCO2, NR3C2, CBR3 | TDP1 4767/4885ATM 4819/4885HIF1A 2754/4885 |
| US-20150182549-A1 | METHOD FOR ENZYMATIC GLYCOSYLATION OF OLIGOSACCHARIDES FROM MAMMALIAN ANIMAL MILK | GALE, SI, FUT6 | TDP1 1742/4885ATM 4770/4885HIF1A 4462/4885 |
| US-11208406-B2 | Disubstituted diaryloxybenzoheterodiazole compounds | NR2E3, SCLY, NR2C2 | TDP1 4751/4885ATM 4627/4885HIF1A 2754/4885 |
| US-20220165959-A1 | DISUBSTITUTED FLUOROARYLOXYBENZOHETERODIAZOLE COMPOUNDS | LSS, DDC, HLCS | TDP1 4415/4885ATM 3478/4885HIF1A 2744/4885 |
| US-11706979-B2 | Disubstituted diaryloxybenzoheterodiazole compounds | SCLY, NR2E3, CDK15 | TDP1 4805/4885ATM 4493/4885HIF1A 4421/4885 |
| US-20150183816-A1 | MODIFIED GALACTOOLIGOSACCHARIDES | FUT6, GALE, FUT5 | TDP1 2508/4885ATM 3892/4885HIF1A 2627/4885 |
| US-20140234912-A1 | METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | LCT, B4GALT1, GALNT1 | TDP1 2493/4885ATM 4067/4885HIF1A 3833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.